Farrell Simon
Chief Commercial Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trevi Therapeutics, Inc. (TRVI) | Pharm. D. Chief Commercial Officer | $370,067 | $1,355,897 |
| 2024 | Trevi Therapeutics, Inc. (TRVI) | Pharm. D. Chief Commercial Officer | — | — |
Earnings-call appearances
-
Trevi Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-05
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q4 FY2025 Earnings Call2026-03-17
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-13
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-07
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q1 FY2025 Earnings Call2025-06-02
Trevi Therapeutics, Inc. (TRVI)